The global Gemcitabine HCl Market, valued at US$ 635.1 million in 2021, is poised for significant growth, projected to expand at a compound annual growth rate (CAGR) of 7.8% from 2022 to 2031, surpassing US$ 1.3 billion by the end of the forecast period. Gemcitabine HCl, a chemotherapy drug primarily used to treat cancers such as pancreatic, breast
The global Post-operative Pain Therapeutics Market, valued at US$ 13.0 billion in 2021, is set to experience robust growth, projected to expand at a compound annual growth rate (CAGR) of 5.7% from 2022 to 2031, reaching over US$ 22.3 billion by the end of the forecast period. Post-operative pain, a common consequence of surgical procedures, signifi
The global Cognitive Disorders Treatment Market, valued at US$ 5.5 billion in 2022, is poised for steady growth, with projections indicating a compound annual growth rate (CAGR) of 5.2% from 2023 to 2031, surpassing US$ 8.6 billion by the end of the forecast period. Cognitive disorders, including Alzheimer's disease, dementia, mild cognitive impair
The global subcutaneous immunoglobulin (SCIG) market, valued at US$ 4.0 billion in 2018, is poised for significant growth, with projections indicating expansion at a compound annual growth rate (CAGR) of 13.1% from 2019 to 2027. Subcutaneous immunoglobulin therapy, used primarily for the treatment of primary and secondary immunodeficiencies, offers